Fulgent Genetics, Inc.
NASDAQ:FLGT
22.27 (USD) • At close September 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Revenue
| 283.47 | 289.213 | 618.968 | 992.584 | 421.712 |
| Cost of Revenue
| 176.255 | 184.757 | 252.067 | 215.533 | 89.807 |
| Gross Profit
| 107.215 | 104.456 | 366.901 | 777.051 | 331.905 |
| Gross Profit Ratio
| 0.378 | 0.361 | 0.593 | 0.783 | 0.787 |
| Reseach & Development Expenses
| 48.816 | 41.44 | 28.91 | 24.219 | 11.58 |
| General & Administrative Expenses
| 88.106 | 88.999 | 111.074 | 50.732 | 15.215 |
| Selling & Marketing Expenses
| 36.246 | 41.467 | 38.918 | 24.439 | 14.952 |
| SG&A
| 124.352 | 130.466 | 149.992 | 75.171 | 30.167 |
| Other Expenses
| 7.965 | 128.079 | 9.472 | 1.708 | 0 |
| Operating Expenses
| 181.133 | 299.396 | 188.374 | 101.098 | 41.747 |
| Operating Income
| -73.918 | -195.529 | 178.527 | 675.953 | 290.158 |
| Operating Income Ratio
| -0.261 | -0.676 | 0.288 | 0.681 | 0.688 |
| Total Other Income Expenses Net
| 21.962 | 21.444 | 5.498 | 1.347 | 1.526 |
| Income Before Tax
| -51.956 | -174.085 | 184.025 | 677.3 | 291.684 |
| Income Before Tax Ratio
| -0.183 | -0.602 | 0.297 | 0.682 | 0.692 |
| Income Tax Expense
| -8.136 | 1.154 | 42.102 | 174.795 | 72.532 |
| Net Income
| -42.708 | -167.825 | 143.403 | 507.364 | 214.31 |
| Net Income Ratio
| -0.151 | -0.58 | 0.232 | 0.511 | 0.508 |
| EPS
| -1.41 | -5.63 | 4.76 | 17.13 | 9.44 |
| EPS Diluted
| -1.41 | -5.63 | 4.63 | 16.26 | 8.91 |
| EBITDA
| -48.99 | -46.552 | 221.585 | 686.957 | 293.12 |
| EBITDA Ratio
| -0.173 | -0.161 | 0.358 | 0.692 | 0.695 |